Sharp Biomedical Closes Pre-Seed Funding Led by Gener8tor to Advance Outpatient Spine Procedures for Early-to-Mid-Stage Chronic Pain

FARGO, N.D., Oct. 12, 2026 /PRNewswire/ -- Sharp Biomedical, a medical device company pioneering accessible, safe, and manual procedures for outpatient pain clinics, announced today the successful closing of its pre-seed funding round. The round was led by gener8tor 1889, a North Dakota...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.